
    
      After obtaining written informed consent, patients with mild to moderate CTS will been
      randomized into intervention and control group. Participants in intervention group received
      one-dose ultrasound-guided hydrodissection with 3cc Vitamin B12 and control side received
      one-dose ultrasound-guided injection 3cc normal saline. No additional treatment after
      injection through the study period. The primary outcome is Boston Carpal Tunnel Syndrome
      Questionnaire (BCTQ) and secondary outcomes include visual analog scale (VAS),
      cross-sectional area (CSA) of the median nerve, sensory nerve conduction velocity of the
      median nerve. The evaluation was performed pretreatment as well as on the 2nd week, 1st, 2nd,
      3rd and 6th month after the treatment.
    
  